Overview

Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fasting Condition

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
To evaluate and compare the relative bioavailability and therefore the bioequivalence of two different formulations of donepezil after a single oral dose administration under fasting conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Donepezil